Hydroxyprogesterone Caproate
Who holds supplier records for Hydroxyprogesterone Caproate? 4 organisations hold a current record for Hydroxyprogesterone Caproate: an active US FDA Type II Drug Master File. A further 4 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (2), Netherlands (1) and Italy (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records
Cite as: PharmaTek, “Hydroxyprogesterone Caproate: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/hydroxyprogesterone-caproate
Reading the evidence
- 4 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 4 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (4)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Hydroxyprogesterone Caproate. Country is the organisation's recorded country, not necessarily the manufacturing site.
- ASPEN OSS BVNetherlands Company GMP cert on recordActive DMF 17113 · latest filing Jan 2004
- STEROID SPAItaly Company GMP cert on recordActive DMF 31337 · latest filing Jan 2017
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 28958 · latest filing Feb 2015
- SYMBIOTEC PHARMALAB PRIVATE LTDIndia Company GMP cert on recordActive DMF 30747 · latest filing Jul 2016
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (4)
Organisations whose Type II DMFs for Hydroxyprogesterone Caproate are no longer active. These show a past filing, not current supply.
Show all 4 historical records
- United States · Inactive DMF 32526 · filed Mar 2018
- SCHERING AGInactive DMF 5318 · filed Apr 1984
- DIOSYNTH BVInactive DMF 2993, 3845 · filed May 1980
- UPJOHN COInactive DMF 2856 · filed Feb 1977
Overview
Hydroxyprogesterone Caproate is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1200848).
Chemical identity
- IUPAC name
- [(8R,9S,10R,13S,14S,17R)-17-acetyl-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] hexanoate
- Canonical SMILES
- CCCCCC(=O)O[C@@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)C(=O)C
- InChIKey
- DOMWKUIIPQCAJU-LJHIYBGHSA-N
- Synonyms
- 17.alpha.-caproyloxy-p4, 17-alpha-hydroxyprogesterone, 17.alpha.-hydroxyprogesterone, 17alpha-hydroxyprogesterone, 17-hydroxyprogesterone, 17-ohpc, Caproate d'hydroxyprogesterone, Caproato de hidroxiprogesterona, Delalutin, Depo-proluton, Hidroxiprogesterona, Hormofort
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Progestin
- Chemical structure
- Progesterone Congeners
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Hydroxyprogesterone Caproate?
4 organisations hold an active US FDA Type II Drug Master File or a CEP for Hydroxyprogesterone Caproate: ASPEN OSS BV (Netherlands), STEROID SPA (Italy), Sun Pharmaceutical Industries Limited (India) and SYMBIOTEC PHARMALAB PRIVATE LTD (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Hydroxyprogesterone Caproate Drug Master Files are active?
ASPEN OSS BV (DMF 17113), STEROID SPA (DMF 31337), Sun Pharmaceutical Industries Limited (DMF 28958) and SYMBIOTEC PHARMALAB PRIVATE LTD (DMF 30747). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Hydroxyprogesterone Caproate records mean?
4 organisations have only inactive Type II DMFs for Hydroxyprogesterone Caproate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
How do I qualify a Hydroxyprogesterone Caproate supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Hydroxyprogesterone Caproate?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.